In VivoRising Leaders Home Fibrotic processes are the root cause behind a variety of hard-to-treat diseases, and are key to the scientific approach used by Agomab Therapeutics NV , a Belgian biotech which
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Merck Inks Platform Licensing Agreement